A sublingual formulation of cladribine showed comparable pharmacological properties to its name brand counterpart, Mavenclad.

Researchers have found that combining tolerogenic dendritic cells with Dimethyl Fumarate improves treatment efficacy for ...

Here are the more common treatment options that might be explored: Medications: Known as phosphodiesterase type-5 inhibitors, these drugs are the most commonly prescribed treatment in the U.S ...

Are autoimmune diseases fatal? Normally, your immune system fights off disease and protects your body from infection. However, when you have an autoimmune disease, your immune system ...

Even if you have primary progressive multiple sclerosis (PPMS), which is expected to worsen over time, there is a lot your doctor can do to minimize it. Researching about the latest treatments can ...

Unjustified fears about harm in pregnancy is preventing the use of highly effective medications in women with MS, new ...

Results of a world-first phase 3 trial for secondary progressive multiple sclerosis (MS), led by UCL researchers, have shown ...

Researchers have now ... Treatment at the First Signs of MS Could Mean Lower Risk of Disability Later July 19, 2023 — People who start taking medication soon after the first signs of multiple ...

Multiple sclerosis (MS) is a debilitating autoimmune disease of the brain and spinal cord. The disease can affect everyone differently, but depending on th | Immunology ...

Evidence is rising in favor of using highly effective DMTs to treat pediatric MS, but with few licensed for pediatric use, it ...

Plasma exchange therapy is effective for severe relapses in MS patients who respond inadequately to standard corticosteroids, ...

"These findings could potentially reshape how we approach initial MS treatment decisions," Gonçalves said in ... disorder ...